One Cell

Vigeo Therapeutics Inc, based in Cambridge, MA, is a clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics for various types of cancer to enhance patient outcomes. Their focus lies in reprogramming the tumor immune microenvironment (TIME) through the activation of thrombospondin-1 (Tsp-1), a natural anti-tumorigenic protein that combats cancer cells and inhibits metastasis. Currently, Vigeo is conducting clinical trials for VT1021, a peptide therapeutic agent, in patients with pancreatic, ovarian, triple negative breast cancers, glioblastoma, and tumors with elevated levels of CD36. Their mission is to revolutionize cancer treatment by harnessing the body's own defenses against cancer and improving the lives of those affected by the disease.Generated from the website

Foresight Regulatory Strategies Inc. is a company based in North Andover, Massachusetts, specializing in regulatory and clinical quality consulting. Their expertise assists clients in navigating complex regulatory environments to ensure compliance and enhance operational efficiency. The firm is dedicated to providing strategic advice and support tailored to the unique needs of their clients while leveraging years of industry experience. With a focus on delivering high-quality solutions, Foresight Regulatory Strategies Inc. aims to facilitate successful outcomes in regulatory matters. Generated from the website

From the beginning Topaz has always focused on the wide format document needs of Architects, Engineers, Designers and CAD professionals.